Wysham C, Bhargava A, Chaykin L, de la Rosa R, Handelsman Y, Troelsen LN, Kvist K, Norwood P
Furthermore, in the first patient, hyperpigmentation developed after introduction of doxycycline 300 mg/day, and significantly diminished after stopping doxycycline, while hydroxychloroquine was continued
Hence, by addressing these methodological limitations, such as adequacy of follow-up, generalizability, outcome measures, and small sample sizes, future research can provide more robust evidence of the potential benefits and risks of GLP-1 RAs in psychiatric disorders
Companies like Noom and Hims have also launched programs to prescribe microdosed GLP-1s, claiming that these smaller doses can reduce metabolic risk, lower inflammatory markers, and even lower the risk of cognitive decline. Evidence of sustained patient use post-shortage: Prescription volume and utilization of compounded semaglutide and tirzepatide have continued to grow despite the end of medication shortages, suggesting that compounders may be leveraging additives or dosage adjustments to justify production
Derosa et al
In either case, Jarrow Sustain or Life Extension NAC are better fits
